Postoperative pain control after cesarean section: can diclofenac sodium be used instead of meperidine?

Nuray Bozkurt, Mertihan Kurdoglu, Zehra Kurdoglu, Fatma Kutlusoy, Kutay Biberoglu

Journal: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2010;22(12):1144-50

PMID: 19916712

Abstract

OBJECTIVE

To determine the advantages and disadvantages of the use of diclofenac sodium instead of meperidine for postcesarean section pain control.

METHODS

A total of 130 patients who had undergone cesarean section at the Department of Obstetrics and Gynecology of Gazi University Hospital were prospectively randomised to receive one of two postoperative pain control regimens. The first group of patients received intramuscular diclofenac sodium at a dose of 2 x 75 mg and additional breakthrough meperidine was given intramuscularly at 50 mg dosages each time, if necessary. Patients in the second group received only 6 x 50 mg meperidine.

RESULTS

Twenty-seven of the 65 patients in the diclofenac group complained of unrelieved pain within the subsequent 24 h postoperatively. Patients receiving diclofenac alone or a combination of diclofenac + meperidine were less sedated and the time to the first passing of flatus was shorter than that in the patients treated with only meperidine.

CONCLUSIONS

Diclofenac alone was safe and effective for the majority of the patients and it decreased the opioid requirements in the remaining patients.

Address: Department of Obstetrics and Gynecology, Gazi University School of Medicine, Ankara, Turkey.

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.